Literature DB >> 25918539

A pharmacist's guide to the 2012 update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy.

Margaret L Ackman1, Claudia Bucci1, Michael Callaghan1, Heather Kertland1, Chantal Pharand1, Patrick Robertson1, William Semchuk1.   

Abstract

Year:  2015        PMID： 25918539      PMCID： PMC4366409          DOI： 10.1177/1715163515569572

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN： 1715-1635


× No keyword cloud information.
  32 in total

1.  Characterization of clopidogrel hypersensitivity reactions and management with oral steroids without clopidogrel discontinuation.

Authors:  Asim N Cheema; Atif Mohammad; Tony Hong; Henry R Jakubovic; Gurpreet S Parmar; Waseem Sharieff; M Bernadette Garvey; Michael J B Kutryk; Neil P Fam; John J Graham; Robert J Chisholm
Journal:  J Am Coll Cardiol       Date:  2011-09-27       Impact factor: 24.094

2.  Effect of a prior authorization process on antiplatelet therapy and outcomes in patients prescribed clopidogrel following coronary stenting.

Authors:  Margaret L Ackman; Michelle M Graham; Carolyn Hui; Ross T Tsuyuki
Journal:  Can J Cardiol       Date:  2006-12       Impact factor: 5.223

3.  Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium.

Authors:  Roxana Mehran; Sunil V Rao; Deepak L Bhatt; C Michael Gibson; Adriano Caixeta; John Eikelboom; Sanjay Kaul; Stephen D Wiviott; Venu Menon; Eugenia Nikolsky; Victor Serebruany; Marco Valgimigli; Pascal Vranckx; David Taggart; Joseph F Sabik; Donald E Cutlip; Mitchell W Krucoff; E Magnus Ohman; Philippe Gabriel Steg; Harvey White
Journal:  Circulation       Date:  2011-06-14       Impact factor: 29.690

4.  The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines.

Authors:  Alan D Bell; André Roussin; Raymond Cartier; Wee Shian Chan; James D Douketis; Anil Gupta; Maria E Kraw; Thomas F Lindsay; Michael P Love; Neesh Pannu; Rémi Rabasa-Lhoret; Ashfaq Shuaib; Philip Teal; Pierre Théroux; Alexander G G Turpie; Robert C Welsh; Jean-François Tanguay
Journal:  Can J Cardiol       Date:  2011 May-Jun       Impact factor: 5.223

Review 5.  Triple antithrombotic therapy in patients with atrial fibrillation who have undergone percutaneous coronary intervention with stent implantation.

Authors:  Arden R Barry; Margaret L Ackman
Journal:  Am J Health Syst Pharm       Date:  2012-09-01       Impact factor: 2.637

6.  Esomeprazole with clopidogrel reduces peptic ulcer recurrence, compared with clopidogrel alone, in patients with atherosclerosis.

Authors:  Ping-I Hsu; Kwok-Hung Lai; Chun-Peng Liu
Journal:  Gastroenterology       Date:  2010-12-07       Impact factor: 22.682

7.  A population-based study of the drug interaction between proton pump inhibitors and clopidogrel.

Authors:  David N Juurlink; Tara Gomes; Dennis T Ko; Paul E Szmitko; Peter C Austin; Jack V Tu; David A Henry; Alex Kopp; Muhammad M Mamdani
Journal:  CMAJ       Date:  2009-01-28       Impact factor: 8.262

8.  Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction.

Authors:  Cynthia A Jackevicius; Ping Li; Jack V Tu
Journal:  Circulation       Date:  2008-02-26       Impact factor: 29.690

9.  Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study.

Authors:  Morten Lamberts; Jonas Bjerring Olesen; Martin Huth Ruwald; Carolina Malta Hansen; Deniz Karasoy; Søren Lund Kristensen; Lars Køber; Christian Torp-Pedersen; Gunnar Hilmar Gislason; Morten Lock Hansen
Journal:  Circulation       Date:  2012-08-06       Impact factor: 29.690

10.  Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study.

Authors:  Mette Charlot; Erik L Grove; Peter Riis Hansen; Jonas B Olesen; Ole Ahlehoff; Christian Selmer; Jesper Lindhardsen; Jan Kyst Madsen; Lars Køber; Christian Torp-Pedersen; Gunnar H Gislason
Journal:  BMJ       Date:  2011-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.